Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Exact Sciences Corp EXAS

Healthcare Biotechnology
Exact Sciences Corporation is a global advanced cancer diagnostics company. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The Company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening, MCED Test Development and MRD Test... see more

Recent & Breaking News (NDAQ:EXAS)

Exact Sciences to participate in J.P. Morgan Healthcare Conference

PR Newswire January 3, 2022

New Data Presented at SABCS® 2021 Strengthen Value of Oncotype DX Breast Recurrence Score® Test to Inform Clinical Decision-making

PR Newswire December 8, 2021

Publication in The New England Journal of Medicine Confirms that Tens of Thousands of Women with Node-positive, Early-stage Breast Cancer Can Avoid Chemotherapy with the Oncotype DX® Test

PR Newswire December 1, 2021

New 20-Year Data Published in Urologic Oncology Validates Adverse Pathology as Predictor of Prostate Cancer Outcomes in Clinically Low-Risk Patients

PR Newswire November 23, 2021

Exact Sciences and Jefferson Health Commence Collaboration on Multi-Cancer Earlier Detection

PR Newswire November 18, 2021

Section 32 Raises $740 Million Venture Fund

PR Newswire November 4, 2021

Exact Sciences announces third quarter 2021 results

PR Newswire November 2, 2021

Exact Sciences to participate in November investor conferences

PR Newswire November 1, 2021

New Cologuard® Modeling Data Show Patient Navigation Matters When Reaching Underserved Populations for Colorectal Cancer (CRC) Screening

PR Newswire October 25, 2021

Exact Sciences schedules third quarter 2021 earnings call

PR Newswire October 8, 2021

Exact Sciences to participate in September investor conferences

PR Newswire September 1, 2021

Renalytix Appoints Daniel J. Levangie to its Board of Directors

GlobeNewswire August 30, 2021

Exact Sciences receives regulatory approval for the Oncotype DX Breast Recurrence Score® Program in Japan

PR Newswire August 16, 2021

Smart Medical Device Could Save Millions of Lives

PR Newswire September 13, 2017

Medical Research Stock Performance Review -- Exact Sciences, DexCom, and PAREXEL

PR Newswire September 13, 2017

Exact Sciences to participate in Baird Global Healthcare Conference

PR Newswire August 30, 2017

Medical Laboratories Stocks on Investors' Radar -- DexCom, Novadaq Technologies, Biocept, and Exact Sciences

PR Newswire August 11, 2017

Watch These 7 Huge Put Purchases In Tuesday Trade

Benzinga.com  August 8, 2017

Exact Sciences to participate in Canaccord Genuity Growth Conference

PR Newswire August 1, 2017

18 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  July 26, 2017